Frontier Scientific Solutions Leverages FTZ Status to Offset Rising Pharma Tariffs

• Frontier Scientific Solutions has positioned its Free Trade Zone (FTZ) at Wilmington International Airport (ILM) as a cost-saving solution for life sciences firms amid looming U.S. trade tariffs on pharmaceutical products and components.

• The FTZ designation enables tariff deferrals, exemptions, and streamlined customs processing, reducing financial burdens and supply chain disruptions for manufacturers, CDMOs, and suppliers.

Frontier Scientific Solutions is leveraging its Free Trade Zone (FTZ) at Wilmington International Airport (ILM) to help life sciences companies mitigate supply chain disruptions and cost increases as new U.S. trade tariffs take effect. The FTZ designation offers tariff deferrals, exemptions, and expedited customs processes, making it a strategic asset for pharmaceutical manufacturers, CDMOs, and suppliers navigating an evolving trade landscape.

“With increased tariffs on pharmaceutical raw materials, components, and finished products, our Free Trade Zone designation ensures that companies can continue to move high-value, temperature-sensitive goods efficiently while reducing unnecessary financial burdens,” said Steve Uebele, Chief Executive Officer of Frontier Scientific Solutions.

A key advantage of Frontier’s FTZ is the ability to defer duties until goods enter the U.S. market or eliminate tariffs entirely if products are re-exported. This flexibility allows pharmaceutical companies to optimize costs while ensuring their supply chains remain stable despite shifting trade policies.

Beyond tariff relief, the FTZ facilitates streamlined customs processing, reducing clearance delays that could otherwise impact the integrity of temperature-sensitive shipments. This efficiency ensures that life-saving therapies reach patients faster and more reliably.

By offering financial stability and supply chain continuity, Frontier Scientific Solutions positions itself as a key partner for global life sciences firms seeking cost-effective solutions amid trade uncertainties. As regulatory challenges continue to impact pharmaceutical logistics, the Wilmington FTZ provides a critical resource for manufacturers looking to maintain competitive market access while minimizing tariff exposure.